Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) belongs to Healthcare sector. Its weekly performance is -15.19%. On last trading day company shares ended up $3.43. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) distance from 50-day simple moving average (SMA50) is 5.74%. On 18 May, Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) announced that its Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”) is now open and the Company is authorized to initiate a Phase 2 clinical study with Resunab™ for the treatment of cystic fibrosis (“CF”). Corbus expects to initiate a Phase 2 clinical study with Resunab in adults with CF within the next 90 days.
Morgan Stanley (NYSE:MS) shares advanced 2.20% in last trading session and ended the day at $38.62. MS Gross Margin is 86.20% and its return on assets is 0.70%. Morgan Stanley (NYSE:MS) quarterly performance is 5.98%. Jonathan Pruzan, Executive Vice President and Chief Financial Officer of Morgan Stanley (NYSE:MS), will speak at the Annual Morgan Stanley U.S. Financials Conference in New York on Tuesday, June 9, 2015, at 12:40 p.m. Eastern Time.
On 27 May, BioMed Realty Trust Inc. (NYSE:BMR) shares advanced 0.82% and was closed at $20.99. BMR EPS growth in last 5 year was 16.80%. BioMed Realty Trust Inc. (NYSE:BMR) year to date (YTD) performance is -1.41%. Robert W. Baird restated their outperform rating on shares of Biomed Realty Trust (NYSE:BMR) in a report released on Saturday. Robert W. Baird currently has a $24.00 price objective on the stock, down from their previous price objective of $25.00.
Campbell Soup Company (NYSE:CPB) ended the last trading day at $48.12. Company weekly volatility is calculated as 1.20% and price to cash ratio as 74.64. Campbell Soup Company (NYSE:CPB) showed a weekly performance of 3.00%. On 22 May, Campbell Soup Co. (NYSE:CPB) reported fiscal third-quarter net income of $182 million. On a per-share basis, the Camden, New Jersey-based company said it had profit of 58 cents. Earnings, adjusted for restructuring costs, were 62 cents per share. The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 51 cents per share.
SJW Corp. (NYSE:SJW) shares advanced 1.49% in last trading session and ended the day at $29.94. SJW Gross Margin is 81.10% and its return on assets is 4.50%. SJW Corp. (NYSE:SJW) quarterly performance is -6.75%. SJW Corporation (NYSE:SJW) cash dividend payment of $0.195 per share is scheduled to be paid on June 01, 2015.